العودة إلى الأخبار
الابتكارAI Understanding إحاطة

يراهن أليكس زافورونكوف، من شركة Insilico Medicine، على قدرة الصين والذكاء الاصطناعي على تحقيق الإنجاز التالي في صناعة الأدوية

يعتقد أليكس زافورونكوف، من شركة Insilico Medicine، أن الصين والذكاء الاصطناعي قادران على تحقيق الاختراق التالي في صناعة الأدوية.

4 min readRead the original reporting
Source-provided image accompanying Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry's next breakthrough
التقارير المنسوبةتم تسجيل المصدر
الناشر
fortune.com
رابط المصدر
fortune.comhttps://fortune.com/2026/09/18/insilico-medicine-bets-china-and-ai-can-deliver-the-drug-industry-next-breakthrough/
نوع المصدر
التقارير من خلال منفذ إخباري - وليست وثيقة الطرف الأول.

ما لم نتمكن من تأكيده بشكل مستقل: ويعزى هذا الادعاء إلى منفذ اسمه. ولم نتحقق من ذلك مقابل مستند الطرف الأول. (fortune.com)

السياقافهم هذا في 60 ثانية

ابدأ هنا

اختبر نفسكما هو الذكاء الاصطناعي؟ اختبار

ماذا حدث

Insilico Medicine's Alex Zhavoronkov believes China and AI can deliver the drug industry's next breakthrough. The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis. Insilico used AI to identify the disease target and develop the molecule to treat it. The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

يعتقد أليكس زافورونكوف، من شركة Insilico Medicine، أن الصين والذكاء الاصطناعي قادران على تحقيق الاختراق التالي في صناعة الأدوية.

The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis.

Insilico used AI to identify the disease target and develop the molecule to treat it.

The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

تفاصيل المصدر: fortune.com ↗

لماذا يهم

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry. The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology. Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry.

The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

The company's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

Insilico's success could lead to a shift in the way drugs are developed and marketed.

Interactive Mechanism

الآلية التفاعلية: كيف تعمل فعليًا

استكشف التكنولوجيا الأساسية وراء هذا التطور بشكل تفاعلي.

Thinking Budget (Test-Time Tokens):1,024 tokens
Complex Accuracy79%Math & Code Logic
Latency3.2sTime to first full output
Inference Cost$0.0092Per query estimated
Reasoning StyleStep VerificationInternal chain depth
Active Thinking Trace:
1Deconstruct user problem into formal constraints
2Propose candidate hypotheses & step-by-step calculation
3Self-correction: Backtrack and refute subtle edge cases
4Exhaustive consistency check & final output synthesis
Core takeaway: Test-time compute fundamentally changes AI economics. Instead of only scaling during pre-training, giving reasoning models more tokens at inference time allows them to systematically solve PhD-level STEM problems.
التحقق من المفهوم التفاعلي+10 Points
What is AI? Quiz

A route planner searches possible journeys using explicit rules. What does this illustrate about AI?

ماذا تشاهد بعد ذلك

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry. The company's success could lead to a shift in the way drugs are developed and marketed, and its use of AI could help improve the understanding of aging biology.

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry.

The company's success could lead to a shift in the way drugs are developed and marketed.

Insilico's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

The company's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

Insilico's success could help address the issue of longevity inequality.

الأدلة والاختبارات ذات الصلة

ما هو الذكاء الاصطناعي؟أخلاقيات الذكاء الاصطناعيوكلاء الذكاء الاصطناعيشرح نماذج الذكاء الاصطناعيمستقبل الذكاء الاصطناعياختبر ما تعرفه – جرّب اختبارًا مجانيًا للذكاء الاصطناعيابحث عن مصطلح الذكاء الاصطناعي في قاموسنااتبع أداة تعقب إصدار نموذج الذكاء الاصطناعي
وجدت هذا مفيدا؟